Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

1st PDA Europe Annual Meeting

The Future in Injectables

June 28-29, 2016 | Berlin, Germany
Estrel Berlin
Registration Closed

Program Highlights

Brochure Cover

   Download Meeting Guide

Welcome from the Conference Chair

The Future in Injectables

Dear Friends, Colleagues, Collaborators and Peers,

We are all witnessing a paradigm shift in scientific, technical and regulatory approaches to healthcare. Innovative technologies raise the quality and safety of our manufacturing and distribution processes and offer increased efficiencies and flexibilities. Regulatory oversight is becoming increasingly risk based and strives for convergence on a global scale. Our industry is evolving towards an increasingly agile and flexible manufacturing mode that can accommodate shifting demands, deliver innovative therapies, and master current and future healthcare challenges. 21st century manufacturing will be light years away from the traditional approaches we were accustomed to.

On 28-29 June 2016, PDA Europe’s first Annual Meeting The Future in Injectables will provide you with a first-hand opportunity to stay current and comprehend future advances in modern sterile manufacturing and quality oversight. We will offer you a very unique program with new and exciting topics, specifically aimed at reflecting innovative approaches and cutting edge technologies.

Renowned industry leaders and regulators will share their experience with you in daily plenary sessions and a series of parallel tracks. The opening plenary session will focus on strategies developed by partakers in healthcare to strive in the context of globalization and rapid scientific innovation. Concurrent sessions are designed to address many of the current challenges our industry and regulators faces. They will feature over thirty presentations with practical examples and case studies, and offer the perfect blend of industry updates, educational topics, technical advances and trends in regulatory oversight. We will dive deeply into continuous manufacturing, flexible facilities, modern analytical technologies, automation and robotics, blow-fill-seal technology, big data processing and ‘industry 4.0’, serialization and product tracking implementation, data integrity, innovative injection devices, and – last but not least – the related regulatory aspects. The conference will conclude with an outlook to the future of our industry, covering facilities, manufacturing and therapies of the future in a global context.

Opportunities to interact with speakers, industry peers, regulators, exhibitors and PDA leadership will be plenty. They include extended networking breaks, interactive roundtable discussions with PDA chapters from Europe and Japan and a very special European networking reception on the evening of June 28.

As an extended offer, on June 30 and July 1 PDA Europe will be hosting several in-depth training courses that are designed to complement topics presented at the conference.

PDA Europe’s first Annual Meeting The Future of Injectables shows once again PDA’s commitment to bringing manufacturing technology advances to the forefront and facilitating discussions between industry, suppliers and regulators. You will leave the conference richer, both in terms of knowledge and relationships, which will benefit your career and organization.

Mark your calendars now and plan to join us in Berlin/Germany from June 28 to July 1, 2016.

On behalf of the program planning committee and PDA staff, I look forward to welcoming you there!

Ursula Busse, PhD MBA
Quality Intelligence & External Relations
Novartis Group Quality

Conference Chairwoman

× Please read: PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.